Understanding the dopaminergic deficits in Parkinson's disease: Insights into disease heterogeneity

Journal of Clinical Neuroscience

Volumn 16, Issue 5, 2009, Pages 620-625

  Lewis, Simon J G ^a,b   Barker, Roger A ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Basal ganglia; Cognitive; Heterogeneity; Limbic; Motor; Oscillations; Parkinson's disease; Synchronization

Indexed keywords

BASAL GANGLION; DOPAMINERGIC ACTIVITY; HUMAN; NONHUMAN; PARKINSON DISEASE; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PRIORITY JOURNAL; REVIEW; THALAMUS;

BASAL GANGLIA; DOPAMINE; GENETIC HETEROGENEITY; HUMANS; MOTOR ACTIVITY; PARKINSON DISEASE;

EID: 62549145377     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2008.08.020     Document Type: Review

References (82)

1. Chaudhuri K.R., Healy D.G., Schapira A.H., et al. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 5 (2006) 235-245
2. Schrag A., Jahanshahi M., Quinn N., et al. What contributes to quality of life in patients with Parkinson's disease?. J Neurol Neurosurg Psychiatry 69 (2000) 308-312
3. Gray P., and Hildebrand K. Fall risk factors in Parkinson's disease. J Neurosci Nurs 32 (2000) 222-228
4. Aarsland D., Larsen J.P., Tandberg E., et al. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc 48 (2000) 938-942
5. Jellinger K.A. The pathology of Parkinson's disease. Adv Neurol 86 (2001) 55-72
6. Alexander G.E., DeLong M.R., Strick P.L., et al. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9 (1986) 357-381
7. Diamond A., and Jankovic J. Treatment of advanced Parkinson's disease. Expert Rev Neurother 6 (2006) 1181-1197
8. Zetusky W.J., Jankovic J., Pirozzolo F.J., et al. The heterogeneity of Parkinson's disease: clinical and prognostic implications. Neurology 35 (1985) 522-526
9. Graham J.M., and Sagar H.J. A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes. Mov Disord 14 (1999) 10-20
10. Lewis S.J., Foltynie T., Blackwell A.D., et al. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 76 (2005) 343-348
11. Kish S.J., Shannak K., Hornykiewicz O., et al. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 318 (1988) 876-880
12. Leentjens A.F., Verhey F.R., Luijckx G.J., et al. The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease. Mov Disord 15 (2000) 1221-1224
13. Jellinger K.A. Post mortem studies in Parkinson's disease-is it possible to detect brain areas for specific symptoms?. J Neural Transm Suppl 56 (1999) 1-29
14. Paulus W., and Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 50 (1991) 743-755
15. Giladi N., McMahon D., Przedborski S., et al. Motor blocks in Parkinson's disease. Neurology 42 (1992) 333-339
16. Giladi N., McDermott M.P., Fahn S., et al. Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology 56 (2001) 1712-1721
17. Parent A., Sato F., Wu Y., et al. Organization of the basal ganglia: the importance of axonal collateralization. Trends Neurosci 23 (2000) S20-S27
18. DeLong M.R. Wichmann T Circuits and circuit disorders of the basal ganglia. Arch Neurol 64 (2007) 20-24
19. Lee M.S., Rinne J.O., Marsden C.D., et al. The pedunculopontine nucleus: its role in the genesis of movement disorders. Yonsei Med J 41 (2000) 167-184
20. Mitchell I.J., Clarke C.E., Boyce S., et al. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Neuroscience 32 (1989) 213-226
21. Jenkins I.H., Fernandez W., Playford E.D., et al. Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Ann Neurol 32 (1992) 749-757
22. Playford E.D., Jenkins I.H., Passingham R.E., et al. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann Neurol 32 (1992) 151-161
23. Bergman H., Wichmann T., Karmon B., et al. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 72 (1994) 507-520
24. Jahanshahi M., Jenkins I.H., Brown R.G., et al. Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 118 (1995) 913-933
25. Pahapill P.A. Lozano AM The pedunculopontine nucleus and Parkinson's disease. Brain 123 (2000) 1767-1783
26. Zweig R.M., Jankel W.R., Hedreen J.C., et al. The pedunculopontine nucleus in Parkinson's disease. Ann Neurol 26 (1989) 41-46
27. Brown R.G., and Marsden C.D. How common is dementia in Parkinson's disease?. Lancet 2 (1984) 1262-1265
28. Williams-Gray C.H., Foltynie T., Brayne C.E., et al. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 130 (2007) 1787-1798
29. Lees A.J. Smith E Cognitive deficits in the early stages of Parkinson's disease. Brain 106 (1983) 257-270
30. Owen A.M., Roberts A.C., Hodges J.R., et al. Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. Brain 116 (1993) 1159-1175
31. Gotham A.M., Brown R.G., Marsden C.D., et al. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain 111 (1988) 299-321
32. Cools A.R., van den Bercken J.H., Horstink M.W., et al. Cognitive and motor shifting aptitude disorder in Parkinson's disease. J Neurol Neurosurg Psychiatry 47 (1984) 443-453
33. Morris R.G., Downes J.J., Sahakian B.J., et al. Planning and spatial working memory in Parkinson's disease. J Neurol Neurosurg Psychiatry 51 (1988) 757-766
34. Downes J.J., Roberts A.C., Sahakian B.J., et al. Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia 27 (1989) 1329-1343
35. Monchi O., Petrides M., Mejia-Constain B., et al. Cortical activity in Parkinson's disease during executive processing depends on striatal involvement. Brain 130 (2007) 233-244
36. Samuel M., Ceballos-Baumann A.O., Blin J., et al. Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study. Brain 120 (1997) 963-976
37. Dagher A., Owen A.M., Boecker H., et al. The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease. Brain 124 (2001) 1020-1032
38. Mattay V.S., Tessitore A., Callicott J.H., et al. Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol 51 (2002) 156-164
39. Cools R., Stefanova E., Barker R.A., et al. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain 125 (2002) 584-594
40. Monchi O., Petrides M., Doyon J., et al. Neural bases of set-shifting deficits in Parkinson's disease. J Neurosci 24 (2004) 702-710
41. Middleton F.A. Strick PL Basal ganglia output and cognition: evidence from anatomical, behavioral, and clinical studies. Brain Cogn 42 (2000) 183-200
42. Stamm J.S. Electrical stimulation of monkeys' prefrontal cortex during delayed response performance. J Comp Physiol Psychol 67 (1969) 535-546
43. Marie R.M., Barre L., Dupuy B., et al. Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease. Neurosci Lett 260 (1999) 77-80
44. Lewis S.J., Dove A., Robbins T.W., et al. Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 23 (2003) 6351-6356
45. Lewis S.J., Dove A., Robbins T.W., et al. Striatal contributions to working memory: a functional magnetic resonance imaging study in humans. Eur J Neurosci 19 (2004) 755-760
46. Albin R.L., Young A.B., Penney J.B., et al. The functional anatomy of basal ganglia disorders. Trends Neurosci 12 (1989) 366-375
47. Lange K.W., Robbins T.W., Marsden C.D., et al. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology (Berl) 107 (1992) 394-404
48. Lange K.W., Paul G.M., Naumann M., et al. Dopaminergic effects on cognitive performance in patients with Parkinson's disease. J Neural Transm Suppl 46 (1995) 423-432
49. Lewis S.J., Slabosz A., Robbins T.W., et al. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease. Neuropsychologia 43 (2005) 823-832
50. Cools R., Barker R.A., Sahakian B.J., et al. Mechanisms of cognitive set flexibility in Parkinson's disease. Brain 124 (2001) 2503-2512
51. Cools R., Lewis S.J., Clark L., et al. L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease. Neuropsychopharmacology 32 (2007) 180-189
52. Foltynie T., Goldberg T.E., Lewis S.G., et al. Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism. Mov Disord 19 (2004) 885-891
53. Williams-Gray C.H., Hampshire A., Robbins T.W., et al. Catechol Omethyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease. J Neurosci 27 (2007) 4832-4838
54. Williams-Gray C.H., Hampshire A., Barker R.A., et al. Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype. Brain 131 (2008) 397-408
55. Voon V., Kubu C., Krack P., et al. Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov Disord 21 (2006) S305-S327
56. Morrison C.E., Borod J.C., Perrine K., et al. Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson's disease. Arch Clin Neuropsychol 19 (2004) 165-181
57. Pillon B., Ardouin C., Damier P., et al. Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease. Neurology 55 (2000) 411-418
58. Jahanshahi M., Ardouin C.M., Brown R.G., et al. The impact of deep brain stimulation on executive function in Parkinson's disease. Brain 123 (2000) 1142-1154
59. Funkiewiez A., Ardouin C., Cools R., et al. Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease. Mov Disord 21 (2006) 1656-1662
60. Grace A.A., Floresco S.B., Goto Y., et al. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 30 (2007) 220-227
61. Brown P. Marsden CD What do the basal ganglia do?. Lancet 351 (1998) 1801-1804
62. Lauterbach E.C. The neuropsychiatry of Parkinson's disease. Minerva Med 96 (2005) 155-173
63. Alegret M., Junque C., Valldeoriola F., et al. Effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease. Arch Neurol 58 (2001) 1223-1227
64. Grosset K.A., Macphee G., Pal G., et al. Problematic gambling on dopamine agonists: Not such a rarity. Mov Disord 21 (2006) 2206-2208
65. Carelli R.M. Deadwyler SA Cellular mechanisms underlying reinforcement related processing in the nucleus accumbens: electrophysiological studies in behaving animals. Pharmacol Biochem Behav 57 (1997) 495-504
66. Wilson C., Nomikos G.G., Collu M., et al. Dopaminergic correlates of motivated behavior: importance of drive. J Neurosci 15 (1995) 5169-5178
67. Cousins M.S. Salamone JD Nucleus accumbens dopamine depletions in rats affect relative response allocation in a novel cost/benefit procedure. Pharmacol Biochem Behav 49 (1994) 85-91
68. Balleine B., and Killcross S. Effects of ibotenic acid lesions of the nucleus accumbens on instrumental action. Behav Brain Res 65 (1994) 181-193
69. Knutson B. Gibbs SE Linking nucleus accumbens dopamine and blood oxygenation. Psychopharmacology (Berl) 191 (2007) 813-822
70. Daniele A., Albanese A., Contarino M.F., et al. Cognitive and behavioural effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 74 (2003) 175-182
71. Funkiewiez A., Ardouin C., Caputo E., et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry 75 (2004) 834-839
72. Castelli L., Perozzo P., Zibetti M., et al. Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits. Eur Neurol 55 (2006) 136-144
73. Drapier D., Drapier S., Sauleau P., et al. Does subthalamic nucleus stimulation induce apathy in Parkinson's disease?. J Neurol 253 (2006) 1083-1091
74. Biseul I., Sauleau P., Haegelen C., et al. Fear recognition is impaired by subthalamic nucleus stimulation in Parkinson's disease. Neuropsychologia 43 (2005) 1054-1059
75. Robertson C., and Flowers K.A. Motor set in Parkinson's disease. J Neurol Neurosurg Psychiatry 53 (1990) 583-592
76. Gatev P., Darbin O., Wichmann T., et al. Oscillations in the basal ganglia under normal conditions and in movement disorders. Mov Disord 21 (2006) 1566-1577
77. Kuhn A.A., Kupsch A., Schneider G.H., et al. Reduction in subthalamic 8-35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease. Eur J Neurosci 23 (2006) 1956-1960
78. Brown P., and Williams D. Basal ganglia local field potential activity: character and functional significance in the human. Clin Neurophysiol 116 (2005) 2510-2519
79. Kuhn A.A., Williams D., Kupsch A., et al. Event-related beta desynchronization in human subthalamic nucleus correlates with motor performance. Brain 127 (2004) 735-746
80. Hammond C., Bergman H., Brown P., et al. Pathological synchronization in Parkinson's disease: networks, models and treatments. Trends Neurosci 30 (2007) 357-364
81. Rivlin-Etzion M., Marmor O., Heimer G., et al. Basal ganglia oscillations and pathophysiology of movement disorders. Curr Opin Neurobiol 16 (2006) 629-637
82. Goetz C.G., Tanner C.M., Stebbins G.T., et al. Risk factors for progression in Parkinson's disease. Neurology 38 (1988) 1841-1844